- CA$159.72m
- CA$158.99m
- CA$0.03m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.86 | ||
| Price to Tang. Book | 9.86 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2,470.12 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -61.28% | ||
| Return on Equity | -55.12% | ||
| Operating Margin | -15546.4% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | 0 | 0.35 | 0.07 | 0.03 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Zentek Ltd. is an intellectual property technology company. The Company is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. Its patented technology platform, ZenGUARD, is shown to have enhanced viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The Company is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The Company has installed industrial-scale production equipment to produce the ZenGUARD coating formulation at its York Rd., Guelph, Ontario location, which is permitted for industrial use. It is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.
Directors
- Francis Dube CHM
- Peter Wood PRE
- Gregory Fenton CEO
- Brian Bosse CFO
- James Jordan VOP
- Colin Van Der Kuur VRD
- Frank Klees IND
- Eric Wallman IND
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 29th, 2008
- Public Since
- December 22nd, 2010
- No. of Employees
- 25
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
TSX Venture Exchange- Shares in Issue
- 104,390,928
- Address
- 24 Corporate Ct, GUELPH, N1G 5G5
- Web
- https://www.zentek.com/
- Phone
- +1 7056180900
- Auditors
- BDO Canada LLP
Upcoming Events for ZEN
Similar to ZEN
Hemostemix
TSX Venture Exchange
Innovotech
TSX Venture Exchange
KDA
TSX Venture Exchange
Marvel Biosciences
TSX Venture Exchange
Medicure
TSX Venture Exchange
FAQ
What is the Zentek share price?
As of Today at 24:15 UTC, shares in Zentek are trading at CA$1.53. This share price information is delayed by 15 minutes.
How has the Zentek share price performed this year?
Shares in Zentek last closed at CA$1.53 and the price had moved by +0.66% over the past 365 days. In terms of relative price strength the Zentek share price has underperformed the Toronto Stock Exchange 300 Composite Index by -9.27% over the past year.
What are the analyst and broker recommendations for Zentek?
The overall consensus recommendation for Zentek is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Zentek dividend yield?
Zentek does not currently pay a dividend.
Does Zentek pay a dividend?
Zentek does not currently pay a dividend.
When does Zentek next pay dividends?
Zentek does not currently pay a dividend.
How do I buy Zentek shares?
To buy shares in Zentek you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Zentek?
As of the previous close price of CA$1.53, shares in Zentek had a market capitalisation of CA$159.72m.
Where are Zentek shares listed?
Here are the trading details for Zentek:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: ZEN
What kind of share is Zentek?
Based on an overall assessment of its quality, value and momentum Zentek is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Zentek share price forecast for 2025?
The analyst consensus target price for shares in Zentek is CA$3.00. That is 96.08% above the last closing price of CA$1.53.
Analysts covering Zentek currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Zentek share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zentek. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +75.68%.
As of the last closing price of CA$1.53, shares in Zentek were trading +13.13% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Zentek PE Ratio?
The Zentek PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$1.53.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Zentek?
Zentek's management team is headed by:
- Francis Dube - CHM
- Peter Wood - PRE
- Gregory Fenton - CEO
- Brian Bosse - CFO
- James Jordan - VOP
- Colin Van Der Kuur - VRD
- Frank Klees - IND
- Eric Wallman - IND